Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8309368 | Clinica Chimica Acta | 2018 | 10 Pages |
Abstract
Lenvatinib and regorafenib affected the expression of PD-L1 in the process of anti-HCC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Meng-jun Qiu, Xiao-xiao He, Ning-rui Bi, Meng-meng Wang, Zhi-fan Xiong, Sheng-li Yang,